This site uses cookies to store information on your computer. I'm fine with this Cookie information
Cookie Control

28. Publications

Accepted papers

  1. Jackson C, Bell D, Gunson RN. Deranged liver function tests in a patient with Hepatitis B. Journal of Clinical Virology


  1. Shepherd SJ, McAllister G, Kean J, Wallace LA, Templeton KE, Goldberg DJ, Gunson RN, Aitken C. Development of an avidity assay for detection of recent HIV infections. J Virol Methods. 2015 Feb 23.
  2. Shepherd SJ, Abdelrahman T, MacLean AR, Thomson EC, Aitken C, Gunson, RN. Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort. J Clin Virol. 2015 Feb;65:50-3
  3. Bennett S, Gunson RN, Li K. Hepatitis E virus infection presenting with paraesthesia. Scott Med J. 2015 Feb 6.
  4. Bradley-Stewart AJ, Jesudason N, Michie K, Winter AJ, Gunson RN. Hepatitis E in Scotland: Assessment of HEV infection in two high-risk patient groups with elevated liver enzymes. J Clin Virol. 2015 Feb;63:36-7.
  5. Li KK, Gunson RN, Lush C, Aitken C. Deranged liver function tests in a patient with Hodgkin's lymphoma. J Clin Virol. 2015 Jan;62:118-21.


  1. McLeod A, Weir A, Aitken C, Gunson R, Templeton K, Molyneaux P, McIntyre P, McDonald S, Goldberg D, Hutchinson S. Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing. J Epidemiol Community Health. 2014 Dec;68(12):1182-8.
  2. McAllister G, Innes H, Mcleod A, Dillon JF, Hayes PC, Fox R, Barclay ST, Templeton K, Aitken C, Gunson R, Goldberg D, Hutchinson SJ. Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland. J Clin Virol. 2014 Nov;61(3):359-64.
  3. Schnier C, Wallace L, Tempelton K, Aitken C, Gunson RN, Molyneaux P, McIntyre P, Povey C, Goldberg D, Hutchinson S. Use of laboratory-based surveillance data to estimate the number of people chronically infected with hepatitis B living in Scotland. Epidemiol Infect. 2014 Oct;142(10):2121-30.
  4. Takebe Y, Naito Y, Raghwani J, Fearnhill E, Sano T, Kusagawa S, Mbisa JL, Zhang H, Matano T, Brown AJ, Pybus OG, Dunn D, Kondo M; UK Collaborative Group on HIV Drug Resistance. Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan. J Virol. 2014 Sep 1;88(17):9864-76.
  5. Hué S, Brown AE, Ragonnet-Cronin M, Lycett SJ, Dunn DT, Fearnhill E, Dolling DI, Pozniak A, Pillay D, Delpech VC, Leigh Brown AJ; UK Collaboration on HIV Drug Resistance and the Collaborative HIV, Anti-HIV Drug Resistance Network (CHAIN). Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. AIDS. 2014 Aug 24;28(13):1967-75.
  6. Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, McAllister G, Gunson R, Hutchinson SJ. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 2014 Aug 11;9(8):e104515.
  7. Hodcroft E, Hadfield JD, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D, Leigh Brown AJ; UK HIV Drug Resistance Database; UK CHIC Study. The contribution of viral genotype to plasma viral set-point in HIV infection. PLoS Pathog. 2014 May 1;10(5):e1004112.
  8. McDonald SA, Hutchinson SJ, Innes HA, Allen S, Bramley P, Bhattacharyya D, Carman W, Dillon JF, Fox R, Fraser A, Goldberg DJ, Kennedy N, Mills PR, Morris J, Stanley AJ, Wilks D, Hayes PC. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan. J Viral Hepat. 2014 May;21(5):366-76.
  9. McNaughton AL, Thomson EC, Templeton K, Gunson RN, Leitch EC. Mixed genotype hepatitis C infections and implications for treatment. Hepatology. 2014 Mar;59(3):1209.
  10. Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, Taylor A. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014 Jan;21(1):25-32.
  11. Foster GM, Ambrose JC, Hué S, Delpech VC, Fearnhill E, Abecasis AB, Leigh Brown AJ, Geretti AM; UK HIV Drug Resistance Database. Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. PLoS One. 2014 Jan 15;9(1):e83337.
  12. Bulteel N, Bansi-Matharu L, Churchill D, Dunn D, Bibby D, Hill T, Sabin C, Nelson M; UK Collaborative HIV Cohort (CHIC) Study Group; UK HIV Drug Resistance Database (UK HDRD) Study Group. The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort. J Infect. 2014 Jan;68(1):77-84.
  13. UK Collaborative Group on HIV Drug Resistance. The increasing genetic diversity of HIV-1 in the UK, 2002-2010. AIDS. 2014 Mar 13;28(5):773-80.


  1. Castro H, Pillay D, Cane P, Asboe D, Cambiano V, Phillips A, Dunn DT; UK Collaborative Group on HIV Drug Resistance. Persistence of HIV-1 transmitted drug resistance mutations. J Infect Dis. 2013 Nov 1;208(9):1459-63.
  2. Dolling DI, Dunn DT, Sutherland KA, Pillay D, Mbisa JL, Parry CM, Post FA, Sabin CA, Cane PA; UK HIV Drug Resistance Database (UKHDRD); UK Collaborative HIV Cohort Study (UK CHIC). Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study. J Antimicrob Chemother. 2013 Oct;68(10):2339-43.
  3. McDonald SA, Hutchinson SJ, Mills PR, Bird SM, Cameron S, Dillon JF, Goldberg DJ. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population. Travel Med Infect Dis. 2013 Sep-Oct;11(5):301-9.
  4. Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study. The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults. AIDS. 2013 Sep 10;27(14):2245-53.
  5. Deshpande A, Gunson R, Bradley A, Cameron S. Hepatitis E: the West of Scotland experience. Scott Med J. 2013 Aug;58(3):178-81
  6. Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013 Jul;57(3):201-8.
  7. Koning FA, Castro H, Dunn D, Tilston P, Cane PA, Mbisa JL; UK Collaborative Group on HIV Drug Resistance. Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother. 2013 Jun;68(6):1220-36.
  8. Shepherd SJ, Kean J, Hutchinson SJ, Cameron SO, Goldberg DJ, Carman WF, Gunson RN, Aitken C. A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots. J Clin Virol. 2013 May;57(1):29-35.
  9. McDonald SA, Hutchinson SJ, Palmateer NE, Allen E, Cameron SO, Goldberg DJ, Taylor A. Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J Hepatol. 2013 Mar;58(3):460-6


  1. Roy KM, Galmés-Truyols A, Giménez-Duran J, Anderson E, Prempeh H, González-Candelas F, Bracho MA, Aitken C, Mactier R, Tejera E; Incident Groups in Scotland and Spain. Epidemiology and molecular investigation of hepatitis C infection following holiday haemodialysis. J Hosp Infect. 2012 Nov;82(3):158-63.
  2. Allen EJ, Palmateer NE, Hutchinson SJ, Cameron S, Goldberg DJ, Taylor A. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy. 2012 Sep;23(5):346-52.
  3. McDonald SA, Hutchinson SJ, Cameron SO, Innes HA, McLeod A, Goldberg DJ. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. Int J Drug Policy. 2012 Sep;23(5):353-7.
  4. UK Collaborative Group on HIV Drug Resistance, Dolling D, Sabin C, Delpech V, Smit E, Pozniak A, Asboe D, Brown AL, Churchill D, Williams I, Geretti AM, Phillips A, Mackie N, Murphy G, Castro H, Pillay D, Cane P, Dunn D, Dolling D. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ. 2012 Aug 21;345:e5253.
  5. Bennett S, Gunson RN, McAllister GE, Hutchinson SJ, Goldberg DJ, Cameron SO, Carman WF. Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol. 2012 Jun;54(2):106-9.
  6. O'Leary MC, Hutchinson SJ, Allen E, Palmateer N, Cameron S, Taylor A, Goldberg DJ. The association between alcohol use and hepatitis C status among injecting drug users in Glasgow. Drug Alcohol Depend. 2012 Jun 1;123(1-3):180-9.
  7. Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees. Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. J Antimicrob Chemother. 2012 Apr;67(4):995-1000.
  8. Cullen BL, Hutchinson SJ, Cameron SO, Anderson E, Ahmed S, Spence E, Mills PR, Mandeville R, Forrest E, Washington M, Wong R, Fox R, Goldberg DJ. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention. J Public Health (Oxf). 2012 Mar;34(1):14-23.
  9. Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, Geretti AM, Kelleher P, Mackie N, Muir D, Murphy G, Orkin C, Post F, Rooney G, Sabin C, Sherr L, Smit E, Tong W, Ustianowski A, Valappil M, Walsh J, Williams M, Yirrell D; BHIVA Guidelines Subcommittee. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2012 Jan;13(1):1-44.


  1. Murphy G, Aitken C. HIV testing--the perspective from across the pond. J Clin Virol. 2011 Dec;52 Suppl 1:S71-6.
  2. Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011 Nov;106(11):1978-88.
  3. McDonald SA, Hutchinson SJ, Mills PR, Bird SM, Cameron S, Dillon JF, Goldberg DJ. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population. J Viral Hepat. 2011 Apr;18(4):e126-33
  4. O'Leary MC, Sarwar M, Hutchinson SJ, Weir A, Schofield J, McLeod A, Cameron S, McTaggart C, Banday S, Foster GR, Ahmed S, Fox R, Mills PR, Goldberg DJ, Anderson E. The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance. J Viral Hepat. 2011 Apr;18(4):e126-33.
  5. McDonald SA, Hutchinson SJ, Cameron S, Bird SM, Mills PR, McLeod A, Goldberg DJ. Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007. J Viral Hepat. 2011 Apr;18(4):e61-5. 2010


  1. Barclay ST, Cameron S, Mills PR, Priest M, Ross F, Fox R, Goulding C, Forrest EH, Morris AJ, Neilson M, Stanley AJ. The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993-2007. Scott Med J. 2010 Aug;55(3):4-7.

  2. Uddin G, Shoeb D, Solaiman S, Marley R, Gore C, Ramsay M, Harris R, Ushiro-Lumb I, Moreea S, Alam S, Thomas HC, Khan S, Watt B, Pugh RN, Ramaiah S, Jervis R, Hughes A, Singhal S, Cameron S, Carman WF, Foster GR. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat. 2010 May;17(5):327-35.

  3. Jazayeri SM, Alavian SM, Carman WF. Hepatitis B virus: origin and evolution. J Viral Hepat. 2010 Apr;17(4):229-35.